Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ABL1 | P00519 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | IDE | P14735 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | CA12 | O43570 | 8/20 | 0.54 |
| ▸ | CA1 | P00915 | 8/20 | 0.54 |
| ▸ | CA2 | P00918 | 8/20 | 0.54 |
| ▸ | CA9 | Q16790 | 8/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.53 |
| ▸ | PTPRF | P10586 | 2/20 | 0.51 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5804927 | 0.92 | TDP1 (0.55) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL31378143 | 0.86 | TDP1 (0.68) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL4624128 | 0.86 | TDP1 (0.65) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL29400740 | 0.86 | TDP1 (0.65) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL5806608 | 0.85 | SLC6A4 (0.54) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL31378084 | 0.85 | TDP1 (0.63) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL31378057 | 0.84 | TDP1 (0.69) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL31248180 | 0.84 | TDP1 (0.69) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL31378085 | 0.84 | TDP1 (0.63) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL6974265 | 0.83 | CASP3 (0.56) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250171770-A1 | METHOD FOR SCREENING FOR SEQUENCE THAT REGULATES DISPLAY EFFICIENCY IN POLYNUCLEOTIDE PRESENTATION METHOD | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) | 2025-05-29 | — | — | US | disclosed |
| CN-119470877-A | Biotinylation modified amino acid probe, preparation method and application thereof, and method and application for identifying amino acid binding protein | 同济大学 | 2025-02-18 | — | — | CN | disclosed |
| WO-2025006976-A2 | MRNA DISPLAY LIBRARIES AND METHODS OF USE | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2025-01-02 | — | — | WO | disclosed |
| US-20240342207-A1 | MODIFIED NUCLEIC ACID COMPOSITIONS AND ASSOCIATED METHODS FOR TREATMENT OF PHENYLKETONURIA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2024-10-17 | — | — | US | disclosed |
| WO-2024112880-A1 | B7-H3 TARGETING LIGANDS AND METHODS OF USE | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-05-30 | — | — | WO | disclosed |
| WO-2023162983-A1 | METHOD FOR SCREENING FOR SEQUENCE THAT REGULATES DISPLAY EFFICIENCY IN POLYNUCLEOTIDE PRESENTATION METHOD | 国立大学法人東海国立大学機構 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023015175-A1 | MODIFIED NUCLEIC ACID COMPOSITIONS AND ASSOCIATED METHODS FOR TREATMENT OF PHENYLKETONURIA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-02-09 | — | — | WO | disclosed |
| US-10745692-B2 | Production method for charged non-protein amino acid-containing peptide | THE UNIVERSITY OF TOKYO (JP) | 2020-08-18 | — | — | US | disclosed |
| US-20160289668-A1 | Production Method for Charged Non-Protein Amino Acid-Containing Peptide | THE UNIVERSITY OF TOKYO (JP) | 2016-10-06 | — | — | US | disclosed |
| EP-3031915-A1 | PRODUCTION METHOD FOR CHARGED NON-PROTEIN AMINO ACID-CONTAINING PEPTIDE | The University of Tokyo (JP) | 2016-06-15 | — | — | EP | disclosed |
| WO-2015019999-A1 | PRODUCTION METHOD FOR CHARGED NON-PROTEIN AMINO ACID-CONTAINING PEPTIDE | 国立大学法人東京大学 (JP) | 2015-02-12 | — | — | WO | disclosed |
| WO-2006121234-A1 | BIOTIN-AMINO ACID CONJUGATE USEFUL AS A HYDROGELATOR AND HYDROGEL PREPARED THEREFROM | POSTECH FOUNDATION (KR) | 2006-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240342207-A1 | MODIFIED NUCLEIC ACID COMPOSITIONS AND ASSOCIATED METHODS FOR TREATMENT OF PHENYLKETONURIA | PAH, ALKBH1, METTL16 | TDP1 199/4885MEN1 3943/4885ABL1 485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.